Your browser doesn't support javascript.
loading
Requirement for YAP1 signaling in myxoid liposarcoma.
Trautmann, Marcel; Cheng, Ya-Yun; Jensen, Patrizia; Azoitei, Ninel; Brunner, Ines; Hüllein, Jennifer; Slabicki, Mikolaj; Isfort, Ilka; Cyra, Magdalene; Berthold, Ruth; Wardelmann, Eva; Huss, Sebastian; Altvater, Bianca; Rossig, Claudia; Hafner, Susanne; Simmet, Thomas; Ståhlberg, Anders; Åman, Pierre; Zenz, Thorsten; Lange, Undine; Kindler, Thomas; Scholl, Claudia; Hartmann, Wolfgang; Fröhling, Stefan.
Affiliation
  • Trautmann M; Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Cheng YY; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Jensen P; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Azoitei N; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Brunner I; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hüllein J; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Slabicki M; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
  • Isfort I; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cyra M; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Berthold R; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wardelmann E; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Huss S; Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Altvater B; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Rossig C; Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Hafner S; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Simmet T; Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Ståhlberg A; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Åman P; Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Zenz T; Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Lange U; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
  • Kindler T; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
  • Scholl C; Cells in Motion Cluster of Excellence, University of Münster, Münster, Germany.
  • Hartmann W; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Hospital, Ulm, Germany.
  • Fröhling S; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Hospital, Ulm, Germany.
EMBO Mol Med ; 11(5)2019 05.
Article in En | MEDLINE | ID: mdl-30898787
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Signal Transduction / Liposarcoma, Myxoid / Adaptor Proteins, Signal Transducing Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: EMBO Mol Med Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Signal Transduction / Liposarcoma, Myxoid / Adaptor Proteins, Signal Transducing Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: EMBO Mol Med Year: 2019 Document type: Article